ReviewFrontiers in endocrinology2021

LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity.

Xuehan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.